{"DataElement":{"publicId":"3289495","version":"1","preferredName":"Southwest Oncology Group Patient Registration Eligibility Determination S0812 Serum Type","preferredDefinition":"a subdivision for registration into S0812 for Southwest Oncology Group and the clear liquid part of the blood that remains after blood cells and clotting proteins have been removed related to the act of determining if a Southwest Oncology Group, an NCI-sponsored cooperative group, an adult cancer clinical trials organization, subject is suitable for enrollment in a study according specific protocol criteria  and procedures.","longName":"2697301v1.0:3289483v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2697301","version":"1","preferredName":"Southwest Oncology Group Patient Registration Eligibility Determination","preferredDefinition":"information related to the act of determining if a Southwest Oncology Group, an NCI-sponsored cooperative group, an adult cancer clinical trials organization, subject is suitable for enrollment in a study according specific protocol criteria  and procedures.","longName":"SWOG_PT_REG_ELIG","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2436359","version":"1","preferredName":"Southwest Oncology Group Patient","preferredDefinition":"The Southwest Oncology Group (SWOG) is an NCI-sponsored cooperative group, an adult cancer clinical trials organization, one of the largest in the world. The group was established in 1956 and is headquartered in San Antonio, TX. Its network consists of almost 4,000 of the physicians at 283 institutions throughout the US and Canada. The major goal of the SWOG since 1990 has been to enroll more women and minority patients in cancer treatment and control research trials.:A person who requires medical care.","longName":"C25699:C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Southwest Oncology Group","conceptCode":"C25699","definition":"An NCI-sponsored cooperative group, an adult cancer clinical trials organization, one of the largest in the world. The group was established in 1956 and is headquartered in San Antonio, TX. Its network consists of almost 4,000 of the physicians at 283 institutions throughout the US and Canada. The major goal of the SWOG since 1990 has been to enroll more women and minority patients in cancer treatment and control research trials.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0781A8FE-557E-0C0C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-12-12","modifiedBy":"ONEDATA","dateModified":"2005-12-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2697299","version":"1","preferredName":"Registration Eligibility Determination","preferredDefinition":"Registration; the act of enrolling.:Criteria to determine eligibility of patients for medical care programs and services.","longName":"C25646:C25171","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Registration","conceptCode":"C25646","definition":"The act of listing or recording officially; officially qualified or enrolled.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3EFDF393-5B7B-0361-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-11-15","modifiedBy":"ONEDATA","dateModified":"2007-11-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3EFDF393-5B8C-0361-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-11-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3289483","version":"1","preferredName":"Southwest Oncology Group Patient Registration Eligibility Determination S0812 Serum Type","preferredDefinition":"a subdivision for registration into S0812 for Southwest Oncology Group and the clear liquid part of the blood that remains after blood cells and clotting proteins have been removed.","longName":"3289483v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"< 20 ng/ml","ValueMeaning":{"publicId":"3289484","version":"1","preferredName":"< 20 ng/ml","longName":"3289484","preferredDefinition":"< 20 ng/ml","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE8F47F2-4ED2-E2FA-E040-BB89AD435ECA","latestVersionIndicator":"Yes","beginDate":"2011-10-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-10-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE8F47F2-4EEB-E2FA-E040-BB89AD435ECA","beginDate":"2010-09-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-10-05","modifiedBy":"ONEDATA","dateModified":"2011-10-05","deletedIndicator":"No"},{"value":"2","valueDescription":"20-32 ng/ml","ValueMeaning":{"publicId":"3289485","version":"1","preferredName":"20-32 ng/ml","longName":"3289485","preferredDefinition":"20-32 ng/ml","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE8F47F2-4EF5-E2FA-E040-BB89AD435ECA","latestVersionIndicator":"Yes","beginDate":"2011-10-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-10-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE8F47F2-4F0E-E2FA-E040-BB89AD435ECA","beginDate":"2010-09-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-10-05","modifiedBy":"ONEDATA","dateModified":"2011-10-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3289482","version":"1","preferredName":"Serum Type","preferredDefinition":"The clear liquid part of the blood that remains after blood cells and clotting proteins have been removed.:Type; a subdivision of a particular kind of thing.","longName":"C13325:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serum","conceptCode":"C13325","definition":"The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE8F47F2-4EAB-E2FA-E040-BB89AD435ECA","latestVersionIndicator":"Yes","beginDate":"2011-10-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-10-05","modifiedBy":"ONEDATA","dateModified":"2011-10-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE8F47F2-4EBC-E2FA-E040-BB89AD435ECA","latestVersionIndicator":"Yes","beginDate":"2011-10-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-10-05","modifiedBy":"ALAIS","dateModified":"2011-10-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Baseline serum 25(OH)D level","type":"Preferred Question Text","description":"Baseline serum 25(OH)D level","url":null,"context":"CTEP"}],"origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE8F47F2-4FAD-E2FA-E040-BB89AD435ECA","latestVersionIndicator":"Yes","beginDate":"2011-10-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-10-05","modifiedBy":"ALAIS","dateModified":"2011-10-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}